Cytokinetics ticker
WebMar 4, 2024 · Today is shaping up negative for Cytokinetics, ... (ticker: BBBY) stock was down nearly 20% at 83 cents. In a reverse stock split, each outstanding share is converted into a fraction of the share. WebFeb 15, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced topline results from METEORIC-HF ( M ulticenter E xercise T olerance E...
Cytokinetics ticker
Did you know?
WebCytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 34.71 -0.54 (-1.53%) As of 10:34AM EDT. Market open. WebFeb 28, 2024 · The US FDA has issued a Complete Response Letter to Cytokinetics ( NASDAQ: CYTK) for omecamtiv mecarbil for heart failure with reduced ejection fraction. Shares are down ~8% in post-market trading ...
WebNov 1, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2024 it granted stock options to purchase an aggregate... WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating …
WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete... WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, …
WebApr 20, 2024 · Is CYTK stock a buy? Hedge fund interest in Cytokinetics, Inc. (NASDAQ: CYTK) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that...
WebApr 5, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … earth front liberationWebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. ctgp all tracksWebTicker CYTK. Exchange NASDAQ More. ... Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Visit website. Social Media Links. Cytokinetics. Most Recent … earth frontiersWebTicker: CYTK; CUSIP Number: 23282w605; Tip: Access positions for across all investors ... By clicking the button below, your credit card will be charged $28.00 USD (one time) and you'll have access to all Cytokinetics position data for 90 days. Purchase access * Investors with a full data subscription can access data for any fund and any ticker ... earth from the north poleWeb2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … earthfruitsWebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … ct gov vehicle registrationWebApr 29, 2004 · Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest funding was raised on Jul 1, 2024 from a Post-IPO Debt round. Cytokinetics is … earthfructifera llc